Article
A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications.
Current pharmaceutical design - 1 Jan 2010
Balistreri C R, Caruso C, Carruba G, Miceli V, Campisi I, Listì F, Lio D, Colonna-Romano G, Candore G
Abstract excerpt
Host genetic factors are crucial risk determinants for many human cancers. In this framework, an interesting model is represented by prostate cancer (PC), which is featured by a complex pathophysiology with a strong genetic component. Multiple genes seem to influence PC risk and several single nucleotide polymorphisms (SNPs) of candidate genes modifying PC susceptibility have been identified. It is noteworthy the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
